Literature DB >> 21666403

Respiratory fluoroquinolone use and influenza.

Philip M Polgreen1, Ming Yang, Ramanan Laxminarayan, Joseph E Cavanaugh.   

Abstract

We show that respiratory fluoroquinolone use is extremely seasonal and that fluoroquinolone use is strongly associated with influenza. In our time series model, instantaneous influenza activity was a significant predictor of use (P < .0001). Also, we estimated that reducing influenza activity by 20% would reduce prescriptions by 8%.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21666403      PMCID： PMC3258490          DOI： 10.1086/660859

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  14 in total

1.  Seasonal variation in fluoroquinolone prescribing.

Authors:  S Abell; S Chapman; L Nadin; R Warren
Journal:  J Antimicrob Chemother       Date:  1999-02       Impact factor: 5.790

2.  Antibiotic use in ambulatory care in Europe (ESAC data 1997-2002): trends, regional differences and seasonal fluctuations.

Authors:  Monique M Elseviers; Matus Ferech; Robert H Vander Stichele; Herman Goossens
Journal:  Pharmacoepidemiol Drug Saf       Date:  2007-01       Impact factor: 2.890

3.  The effect of universal influenza immunization on antibiotic prescriptions: an ecological study.

Authors:  Jeffrey C Kwong; Sarah Maaten; Ross E G Upshur; David M Patrick; Fawziah Marra
Journal:  Clin Infect Dis       Date:  2009-09-01       Impact factor: 9.079

4.  Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom.

Authors:  C R Meier; P N Napalkov; Y Wegmüller; T Jefferson; H Jick
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-11       Impact factor: 3.267

5.  The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children.

Authors:  K M Neuzil; B G Mellen; P F Wright; E F Mitchel; M R Griffin
Journal:  N Engl J Med       Date:  2000-01-27       Impact factor: 91.245

6.  A province-level risk factor analysis of fluoroquinolone consumption patterns in Canada (2000-06).

Authors:  Shiona K Glass; David L Pearl; Scott A McEwen; Rita Finley
Journal:  J Antimicrob Chemother       Date:  2010-06-24       Impact factor: 5.790

7.  Declining antibiotic prescriptions for upper respiratory infections, 1993-2004.

Authors:  Stefan G Vanderweil; Andrea J Pelletier; Azita G Hamedani; Ralph Gonzales; Joshua P Metlay; Carlos A Camargo
Journal:  Acad Emerg Med       Date:  2007-02-12       Impact factor: 3.451

8.  Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings.

Authors:  Carlos G Grijalva; J Pekka Nuorti; Marie R Griffin
Journal:  JAMA       Date:  2009-08-19       Impact factor: 56.272

Review 9.  Reducing antibiotic use in influenza: challenges and rewards.

Authors:  D Low
Journal:  Clin Microbiol Infect       Date:  2007-12-18       Impact factor: 8.067

10.  Excess drug prescriptions during influenza and RSV seasons in the Netherlands: potential implications for extended influenza vaccination.

Authors:  M D M Assink; J P Kiewiet; M H Rozenbaum; P B Van den Berg; E Hak; E J Buskens; J C Wilschut; A C M Kroes; M J Postma
Journal:  Vaccine       Date:  2008-12-09       Impact factor: 3.641
View more
  11 in total

1.  Influence of provider and urgent care density across different socioeconomic strata on outpatient antibiotic prescribing in the USA.

Authors:  Eili Y Klein; Michael Makowsky; Megan Orlando; Erez Hatna; Nikolay P Braykov; Ramanan Laxminarayan
Journal:  J Antimicrob Chemother       Date:  2015-01-20       Impact factor: 5.790

2.  The Impact of Influenza Vaccination on Antibiotic Use in the United States, 2010-2017.

Authors:  Eili Y Klein; Emily Schueller; Katie K Tseng; Daniel J Morgan; Ramanan Laxminarayan; Arindam Nandi
Journal:  Open Forum Infect Dis       Date:  2020-06-06       Impact factor: 3.835

3.  Phantom Prescribing: Examining the Frequency of Antimicrobial Prescriptions Without a Patient Visit.

Authors:  Benjamin N Riedle; Linnea A Polgreen; Joseph E Cavanaugh; Mary C Schroeder; Philip M Polgreen
Journal:  Infect Control Hosp Epidemiol       Date:  2016-12-13       Impact factor: 3.254

4.  Fluoroquinolone Use and Seasonal Patterns of Ciprofloxacin Resistance in Community-Acquired Urinary Escherichia coli Infection in a Large Urban Center.

Authors:  Jean-Paul R Soucy; Alexandra M Schmidt; Caroline Quach; David L Buckeridge
Journal:  Am J Epidemiol       Date:  2020-03-02       Impact factor: 4.897

5.  The effect of generic market entry on antibiotic prescriptions in the United States.

Authors:  Cecilia Kållberg; Jemma Hudson; Hege Salvesen Blix; Christine Årdal; Eili Klein; Morten Lindbæk; Kevin Outterson; John-Arne Røttingen; Ramanan Laxminarayan
Journal:  Nat Commun       Date:  2021-05-18       Impact factor: 14.919

6.  Seasonality of Clostridium difficile infections in Southern Germany.

Authors:  M Reil; M P M Hensgens; E J Kuijper; T Jakobiak; H Gruber; M Kist; S Borgmann
Journal:  Epidemiol Infect       Date:  2011-12-08       Impact factor: 2.451

Review 7.  How Can Vaccines Contribute to Solving the Antimicrobial Resistance Problem?

Authors:  Marc Lipsitch; George R Siber
Journal:  MBio       Date:  2016-06-07       Impact factor: 7.867

Review 8.  Influenza interaction with cocirculating pathogens and its impact on surveillance, pathogenesis, and epidemic profile: A key role for mathematical modelling.

Authors:  Lulla Opatowski; Marc Baguelin; Rosalind M Eggo
Journal:  PLoS Pathog       Date:  2018-02-15       Impact factor: 6.823

9.  Temporal relationship between antibiotic use and respiratory virus activities in the Republic of Korea: a time-series analysis.

Authors:  Sukhyun Ryu; Sojung Kim; Bryan I Kim; Eili Y Klein; Young Kyung Yoon; Byung Chul Chun
Journal:  Antimicrob Resist Infect Control       Date:  2018-04-25       Impact factor: 4.887

10.  Antibiotic prescribing behavior among general practitioners - a questionnaire-based study in Germany.

Authors:  Florian Salm; Sandra Schneider; Katja Schmücker; Inga Petruschke; Tobias S Kramer; Regina Hanke; Christin Schröder; Christoph Heintze; Ulrich Schwantes; Petra Gastmeier; Jochen Gensichen
Journal:  BMC Infect Dis       Date:  2018-05-04       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.